Extrahepatic regional chemotherapy. Use of technetium-99m labeled macroaggregated albumin

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 3, 1999, Pages 315-319

  Pelosi, Ettore ^a   Bellò, Marilena ^a,b   Zanon, Claudio ^a   Grosso, Maurizio ^a   Clara, Renzo ^a   Alabiso, Oscar ^a   Bisi, Gianni ^a   Mussa, Antonio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Dipartimento di Medicina Interna   (Italy)

Author keywords

Nuclear techniques; Perfusion imaging; Regional chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; MACROSALB TC 99M;

ADULT; AGED; ARTERIOVENOUS SHUNT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; IMPLANTATION; MALE; MALIGNANT NEOPLASTIC DISEASE; PATIENT MONITORING; SCINTIGRAPHY;

EID: 0033504656     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199906000-00022     Document Type: Article

References (36)

1. Klopp CT, Alford TC, Bateman JB, et al. Fractionated intraarterial chemotherapy. Ann Surg 1950;132:811-32.
2. Bierman HR, Byron RL, Kelly NH. Treatment of inoperable visceral and regional metastases by intraarterial catheterization. Cancer Res 1951;11:236-9.
3. Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional vs systemic continuous 5-FU chemotherapy in the treatment of colorectal metastases. Ann Surg 1987; 206:685-93.
4. Honn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous vs hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver. The Northern California Oncology Trial. Clin Oncol 1989;7:1646-54.
5. Martin JK, O'Connel NJ, Wieand HS, et al. Intraarterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990;126:1022-7.
6. Kemeny N, Daly J, Reichman B, et al. Intrahepatic or systemic infusion of fluorodeoxyridina in patients with liver metastases from colorectal carcinoma: a randomized trial. Ann Intern Med 1987;107:459-65.
7. Rougier P, Hay JM, Olivier JM, et al. A controlled multicentric trial of intrahepatic artery chemotherapy vs standard palliative treatment for colorectal liver metastases [abstract]. Proc Am Soc Clin Oncol 1990;9:104.
8. Arisawa Y, Sutanto WE, Fortunato L, Sigurdson ER. Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: a regional antiangiogenic therapy. Ann Surg Oncol 1995;2: 114-20.
9. Kemeny N, Conti JA, Cohen A, et al. Phase 2 study of hepatic arterial fluoxuridine, leucovorin and dexamethasone for unresectable liver metastases from colorectal cancer. J Clin Oncol 1994; 12:2288-95.
10. Kemeny MM, Alava G, Oliver JM. The effect on liver metastases of circadian patterned continuous hepatic artery infusion of FUDR. Hepato-Pancreatic-Biliary Surg 1994;7:219-24.
11. Kemeny N, Seiter K, Conti JA, et al. Hepatic arterial fluoxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Cancer 1994; 73:1134-42.
12. Tokats PG, Kerr DJ, Poole CJ, et al. Hepatic arterial chemotherapy for metastatic colorectal carcinoma. Br J Cancer 1994;2:372-8.
13. Boyle FM, Smith RC, Levi JA. Continuous hepatic artery infusion of 5-fluorouracil for metastatic colorectal cancer localized to the liver. Aust N Z J Med 1993;1:32-4.
14. Lorenz M, Hottenrott C, Encke A. Adjuvant regional chemotherapy after resection of liver metastases of primary colorectal tumours. Zentralb Chir 1993;118:279-89.
15. Sugarbaker PH, Stevens MA. A cytoreductive approach to treatment of multiple liver metastases. J Surg Oncol 1993;3(suppl): 161-5.
16. Kemeny N, Conti JA, Sigurdson E, et al. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Cancer 1993;71:1964-71.
17. Meta-Analysis Group in Cancer et al. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996;88:252-8.
18. Zanon C, Grosso M, Zanon E, et al. Transaxillary access to perform hepatic artery infusion (HAI) for secondary or primitive hepatic tumors. Minerva Chir 1996;51(9):755-8.
19. Grosso M, Zanon C. Transaxillary access to perform hepatic artery infusion (HAI) for secondary or primitive hepatic tumors. Eur J Cancer 1996;32:1824-5.
20. Grosso M, Zanon C, Alabiso O, et al. Insercion percutanea de port arterial para quimterapia locoregional de las metastasis hepaticas. Oncologia 1997;20:145-9.
21. Zanon C, Grosso M, Zanon E, et al. Posizionamento percutaneo di cateteri intra-arteriosi con reservoir sottocutaneo per infusione: tecnica e risultati preliminari. Radiol Med 1997;94(3):226-32.
22. Yamada T, Oshugi F, Irie T, et al. Extended intraarterial cisplatin infusion for treatment of gynecologic cancer after alteration of intrapelvic blood flow and implantation of vascular access device. Cardiovasc Intervent Radiol 1996;19:139-45.
23. Link KH, Formentini A, Gansauge F, et al. Regional celiac artery infusion as adjuvant treatment after pancreatic cancer resection. Digestion 1997;58:529-32.
24. Muchmore JH, Preslan JE, George WJ. Regional chemotherapy for inoperable pancreatic carcinoma. Cancer 1996;78(suppl 3):664-73.
25. Shani J, Bertram J, Russell C, et al. Noninvasive monitoring of drug biodistribution and metabolism: studies with intraarterial Pt-195m-cisplatin in humans. Cancer Res 1989;49:1877-81.
26. Ishikawa H, Kikkawa F, Tamakoshi K, et al. Distribution of platinum in human gynecologic tissues and lymph nodes after intravenous and intraarterial neoadjuvant chemotherapy. Anticancer Res 1996;16:3849-54.
27. Kaplan WD, D'Orsi CJ, Ensminger WD, et al. Intra-arterial radionuclide infusion: new technique to assess chemotherapy perfusion patterns. Cancer Treat Rep 1978;62:699-703.
28. Kaplan WD, Ensminger WD, Come SE, et al. Radionuclide angiography to predict patients' response to hepatic artery chemotherapy. Cancer Treat Rep 1980;64:1217-22.
29. Bledin AG, Kim EE, Karle TS, et al. Technetium-99m-labeled macroaggregated albumin arteriography for detection of abnormally positioned arterial catheters during infusion chemotherapy. Cancer 1984;53:858-62.
30. Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974;75:589-96.
31. Strohmeyer T, Haugeberg G, Lierse W. Angioarchitecture and blood supply of micro- and macrometastases in human livers. An anatomic-pathological investigation using injection-techniques. J Hepathol 1987;4:181-9.
32. Lin G, Lunderquist A, Hägerstrand I, et al. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery 1984;96:517-26.
33. Archer SG, Gray BN. Vascularization of small liver metastases. Br J Surg 1989;76:545-8.
34. Tetsuro K, Kazunari S, Ryusei S, et al. Targeted cancer chemotherapy with arterial microcapsule chemoembolization: review of 1013 patients. Cancer Chemother Pharmacol 1996;37:289-96.
35. Kaplan WD, Come SE, Takvorian RW, et al. Pulmonary uptake of Tc-99m MAA: a predictor of gastrointestinal toxicity during hepatic artery perfusion. J Clin Oncol 1984;2:1266-9.
36. Gyves JW, Ziessman HA, Ensminger WD, et al. Definition of tumor microcirculation by single photon emission cumputerised tomography (SPECT). J Nucl Med 1984;25:972-7.